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All influenza vaccines currently sold in Canada require one fertilized chicken egg to produce roughly one dose of 
vaccine.  During pandemic influenza outbreaks, the limited availability of eggs stresses the ability of this method 
to deliver vaccine in a timely manner (1).  Unlike eggs, cell lines grow exponentially, resulting in virtually limitless 
substrate for cultivating influenza vaccines.  This ability to rapidly scale production during periods of increased 
demand is ideal for effectively responding to pandemic influenza outbreaks. While promising, cell-based 
influenza vaccine production suffers from low volumetric yield (~10-fold lower) compared to egg-based methods 
(2).   
 
In this study, a genome-wide screen was used to identify gene knockouts that increase influenza yield in the 
HEK-293SF cell line.  Viral replication is dependent upon a myriad of cellular factors, for example an estimated 
9.5% of human protein-coding genes affect HIV-1 replication (3).  Many of these cellular factors are components 
of the innate immune system and actively inhibit virus replication.  Identifying these factors will allow the 
generation of cell lines where they have been knocked out, enhancing influenza yield.   
 
To carry out the screen, knockouts were induced with a lentivirus-vectored, pooled CRISPR/Cas9 library.  Cells 
were then infected with Green Fluorescence Protein (GFP)-tagged influenza.  Cells with a favorable 
environment for influenza replication expressed high amounts of GFP, allowing them to be collected using 
Fluorescence Assisted Cell Sorting.  Next Generation Sequencing was then used to determine which knockouts 
enhanced influenza replication.   
 
The results of the screen will inform the generation of high-yield vaccine production cell lines based on the HEK-
293SF parent line, advancing efforts towards cell-based vaccine production methods that are able to effectively 
address pandemic outbreaks.  The results also offer insights into the host determinants of influenza infection 
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